Results 221 to 230 of about 113,823 (359)
Balancing Promise and Peril: Hemophilia Gene Therapy Insights. [PDF]
Akula S +4 more
europepmc +1 more source
ABSTRACT Objectives To assess the effectiveness and safety of damoctocog alfa pegol in patients with severe and nonsevere hemophilia A in the fifth interim analysis of the ongoing HEM‐POWR study. Methods HEM‐POWR (NCT03932201) is a multinational, Phase 4, prospective observational study.
Mark T. Reding +7 more
wiley +1 more source
PB2654: RARE BLEEDING DISORDERS: LONG-TERM EXPERIENCE FROM A HEMOPHILIA CENTER
Antonios Meimaridis +5 more
doaj +1 more source
66. Effective Treatment of Hemophilia A Using Hematopoietic Stem Cell Transplantation and a Bioengineered Factor VIII Transgene [PDF]
openalex +1 more source
Predicting FVIII Activity in Patients Who Use Recombinant FVIII Fc Fusion Protein for Prophylaxis and Treatment of Bleeding Episodes [PDF]
Allen, G +7 more
core
Health care resources and costs associated with delivering gene therapy for hemophilia in clinical practice. [PDF]
Prameyllawati DM +9 more
europepmc +1 more source

